KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
-
Published:2022-06
Issue:
Volume:238
Page:157-172
-
ISSN:0002-9394
-
Container-title:American Journal of Ophthalmology
-
language:en
-
Short-container-title:American Journal of Ophthalmology
Author:
Brown David M.,
Emanuelli Andrés,
Bandello FrancescoORCID,
Barranco Jose Juan EscobarORCID,
Figueira JoãoORCID,
Souied Eric,
Wolf SebastianORCID,
Gupta VishaliORCID,
Ngah Nor FarizaORCID,
Liew Gerald,
Tuli RamanORCID,
Tadayoni RaminORCID,
Dhoot Dilsher,
Wang Lixin,
Bouillaud Emmanuel,
Wang Ying,
Kovacic Lidija,
Guerard Nicolas,
Garweg Justus G.ORCID
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献